Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech fireworks -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (2553)	7/18/2006 3:35:52 PM
From: tuck	Read Replies (1) \| Respond to of 7424

It's really been a while since there's been a legitimate posting here -- two weeks -- since I don't recall FRX quite making the cut in actuality. That's how tough this bear has been lately. Be that as it may, TRCA just took off, about 22%. Don't see any news since the patent ruling a couple of weeks ago. Can't say I understand the ins and outs of the INSM/TRCA dispute. I gather INSM's compound has a dosing advantage, but at least some of the IP battle seems to be going TRCA's way? Whatever, it stands out on a day like today. Cheers, Tuck